IBDEI2TG ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47280,1,4,0)
 ;;=4^C81.36
 ;;^UTILITY(U,$J,358.3,47280,2)
 ;;=^5001427
 ;;^UTILITY(U,$J,358.3,47281,0)
 ;;=C81.37^^209^2346^262
 ;;^UTILITY(U,$J,358.3,47281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47281,1,3,0)
 ;;=3^Lymphocyte Depleted Classical Hodgkin Lymphoma,Spleen
 ;;^UTILITY(U,$J,358.3,47281,1,4,0)
 ;;=4^C81.37
 ;;^UTILITY(U,$J,358.3,47281,2)
 ;;=^5001428
 ;;^UTILITY(U,$J,358.3,47282,0)
 ;;=C81.38^^209^2346^263
 ;;^UTILITY(U,$J,358.3,47282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47282,1,3,0)
 ;;=3^Lymphocyte Depleted Classical Hodgkin Lymphoma,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,47282,1,4,0)
 ;;=4^C81.38
 ;;^UTILITY(U,$J,358.3,47282,2)
 ;;=^5001429
 ;;^UTILITY(U,$J,358.3,47283,0)
 ;;=C81.39^^209^2346^264
 ;;^UTILITY(U,$J,358.3,47283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47283,1,3,0)
 ;;=3^Lymphocyte Depleted Classical Hodgkin Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,47283,1,4,0)
 ;;=4^C81.39
 ;;^UTILITY(U,$J,358.3,47283,2)
 ;;=^5001430
 ;;^UTILITY(U,$J,358.3,47284,0)
 ;;=C81.40^^209^2346^265
 ;;^UTILITY(U,$J,358.3,47284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47284,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,47284,1,4,0)
 ;;=4^C81.40
 ;;^UTILITY(U,$J,358.3,47284,2)
 ;;=^5001431
 ;;^UTILITY(U,$J,358.3,47285,0)
 ;;=C81.41^^209^2346^266
 ;;^UTILITY(U,$J,358.3,47285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47285,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,47285,1,4,0)
 ;;=4^C81.41
 ;;^UTILITY(U,$J,358.3,47285,2)
 ;;=^5001432
 ;;^UTILITY(U,$J,358.3,47286,0)
 ;;=C81.42^^209^2346^267
 ;;^UTILITY(U,$J,358.3,47286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47286,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,47286,1,4,0)
 ;;=4^C81.42
 ;;^UTILITY(U,$J,358.3,47286,2)
 ;;=^5001433
 ;;^UTILITY(U,$J,358.3,47287,0)
 ;;=C81.43^^209^2346^268
 ;;^UTILITY(U,$J,358.3,47287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47287,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,47287,1,4,0)
 ;;=4^C81.43
 ;;^UTILITY(U,$J,358.3,47287,2)
 ;;=^5001434
 ;;^UTILITY(U,$J,358.3,47288,0)
 ;;=C81.44^^209^2346^269
 ;;^UTILITY(U,$J,358.3,47288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47288,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,47288,1,4,0)
 ;;=4^C81.44
 ;;^UTILITY(U,$J,358.3,47288,2)
 ;;=^5001435
 ;;^UTILITY(U,$J,358.3,47289,0)
 ;;=C81.45^^209^2346^270
 ;;^UTILITY(U,$J,358.3,47289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47289,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,47289,1,4,0)
 ;;=4^C81.45
 ;;^UTILITY(U,$J,358.3,47289,2)
 ;;=^5001436
 ;;^UTILITY(U,$J,358.3,47290,0)
 ;;=C81.46^^209^2346^271
 ;;^UTILITY(U,$J,358.3,47290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47290,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,47290,1,4,0)
 ;;=4^C81.46
 ;;^UTILITY(U,$J,358.3,47290,2)
 ;;=^5001437
 ;;^UTILITY(U,$J,358.3,47291,0)
 ;;=C81.47^^209^2346^272
 ;;^UTILITY(U,$J,358.3,47291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47291,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Spleen
 ;;^UTILITY(U,$J,358.3,47291,1,4,0)
 ;;=4^C81.47
 ;;^UTILITY(U,$J,358.3,47291,2)
 ;;=^5001438
 ;;^UTILITY(U,$J,358.3,47292,0)
 ;;=C81.48^^209^2346^273
 ;;^UTILITY(U,$J,358.3,47292,1,0)
 ;;=^358.31IA^4^2
